Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
169.71-1.92 (-1.12%)
At close: 4:00 PM EDT

170.44 0.73 (0.43%)
Pre-Market: 8:12 AM EDT

People also watch:
BIIBGILDCELGMRKBMY
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open172.22
Prev Close171.63
Bid169.75 x 100
Ask171.77 x 300
Day's Range169.05 - 172.22
52wk Range135.64 - 176.85
1y Target EstN/A
Market Cap127B
P/E Ratio (ttm)17.37
Beta1.34
Volume2,961,818
Avg Vol (3m)2,840,878
Dividend & Yield4.00 (2.33%)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Amgen, Inc. breached its 50 day moving average in a Bearish Manner : AMGN-US : September 29, 2016
    Capital Cube12 minutes ago

    Amgen, Inc. breached its 50 day moving average in a Bearish Manner : AMGN-US : September 29, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Amgen, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • MarketWatch56 minutes ago

    Amgen and Arrowhead Pharma agree 2 cardiovascular collaborations

    Amgen Inc. and Arrowhead Pharmaceuticals Inc. said Thursday they have agreed to two cardiovascular collaborations. Under one agreement, Amgen will receive an exclusive license option to Arrowhead's proprietary ...

  • Reuters1 hour ago

    Amgen and Arrowhead to develop gene-therapies for heart disease

    Amgen Inc said on Thursday it would buy a stake in Arrowhead Pharmaceuticals Inc and team up with the company to develop gene-silencing therapies for heart disease. Pasadena, California-based Arrowhead will get $35 million up front and will be eligible to receive up to $617 million in milestone payments. It will also get $21.5 million from Amgen through an equity investment.